Home
About
Overview
Sharing Data
ORCID
Help
History (1)
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes. Gastroenterology. 2021 08; 161(2):653-668.e16.
View in:
PubMed
subject areas
5-Methylcytosine
Animals
Antineoplastic Combined Chemotherapy Protocols
Ascorbic Acid
Biomarkers, Tumor
Carcinoma, Pancreatic Ductal
Cell Differentiation
Cell Line, Tumor
Dioxygenases
DNA Methylation
DNA-Binding Proteins
Epigenesis, Genetic
Epigenomics
GATA6 Transcription Factor
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
Metformin
Mice
Mice, Nude
Mice, Transgenic
Pancreatic Neoplasms
Retrospective Studies
Smad4 Protein
Transcription, Genetic
Transcriptome
Wnt Signaling Pathway
Xenograft Model Antitumor Assays
authors with profiles
Somnath Mukherjee